Home > Healthcare > Medical Devices > Diagnostic Devices > Molecular Diagnostics Market
Molecular Diagnostics Market Share
- Report ID: GMI434
- Published Date: Apr 2023
- Report Format: PDF
Molecular Diagnostics Market Share
Some of the leading companies in the molecular diagnostics market include:
- Qiagen
- Agilent Technologies Inc
- bioMerieux SA
- Quidel Corporation
- Biocartis
- Bio-Rad Laboratories
- F. Hoffmann-La Roche AG
- Danaher Corporation
- Hologic Inc
- Becton
- Dickinson and Company
- Illumina Inc
- Sysmex Corporation
- Siemens Healthineers
- Abbott Laboratories
- Thermo Fisher Scientific Inc
These firms are foraying into strategic alliances to extend collaboration and boost innovation.
Frequently Asked Questions (FAQ) :
Global market for molecular diagnostics was worth USD 25 billion in 2022 and is anticipated to record a 3.5% CAGR from 2023-2032.
Hospitals & clinics is anticipated to exhibit a 3.5% CAGR between 2023 and 2032 driven by the increasing R&D collaborations and new research facilities.
North America molecular diagnostics market size is slated to exceed USD 15 billion by 2032 owing to a surge in infectious disease cases and novel outbreaks in the region.
Biocartis, bioMerieux SA., Hologic Inc, Illumina, Inc, Qiagen, Siemens Healthineers, and Sysmex Corporation are some of the leading players in the market.
Molecular Diagnostics Market Scope
×
Get a free sample of
Molecular Diagnostics Market
Inquiry Before Buying
Get special pricing options on this report
Request Sectional Data
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours
below